The Analgesic Efficacy of Perioperative 9-THC (Namisolin) Patients Undergoing Major Abdominal Surgery: A Randomized, Double Blinded, Placebo-controlled, Parallel Design

Trial Profile

The Analgesic Efficacy of Perioperative 9-THC (Namisolin) Patients Undergoing Major Abdominal Surgery: A Randomized, Double Blinded, Placebo-controlled, Parallel Design

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Dronabinol (Primary) ; Diazepam
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms NamiSur
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-005808-17).
    • 11 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top